Clinical Trials Browser

Phase 2 × Recurrent Squamous Cell Carcinoma of the Nasopharynx × Head & Neck × Clear all

NCT01349933 2017-12-05

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

21 enrolled 11 charts

Recurrent Squamous Cell Carcinoma of the Nasopharynx